Low-Dose Stereotactic Body Radiation Therapy-Based Radiation Therapy Followed by Pembrolizumab and Chemotherapy for Potentially Resectable Non-Small Cell Lung Cancer: A Phase 1b Study.

Zhu X, Zhao L, Zhang S, Guo H, Jiang N, Zhang H, Jiang F, Ding N, Ren B, Li M.

Open source

DOI
10.1016/j.ijrobp.2026.05.055
Published
2026-06-09
Container
Int J Radiat Oncol Biol Phys
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijrobp.2026.05.055,
  title = {Low-Dose Stereotactic Body Radiation Therapy-Based Radiation Therapy Followed by Pembrolizumab and Chemotherapy for Potentially Resectable Non-Small Cell Lung Cancer: A Phase 1b Study.},
  author = {Zhu X and  Zhao L and  Zhang S and  Guo H and  Jiang N and  Zhang H and  Jiang F and  Ding N and  Ren B and  Li M.},
  year = {2026},
  journal = {Int J Radiat Oncol Biol Phys},
  doi = {10.1016/j.ijrobp.2026.05.055},
  url = {https://doi.org/10.1016/j.ijrobp.2026.05.055}
}

RIS

TY  - JOUR
TI  - Low-Dose Stereotactic Body Radiation Therapy-Based Radiation Therapy Followed by Pembrolizumab and Chemotherapy for Potentially Resectable Non-Small Cell Lung Cancer: A Phase 1b Study.
AU  - Zhu X
AU  -  Zhao L
AU  -  Zhang S
AU  -  Guo H
AU  -  Jiang N
AU  -  Zhang H
AU  -  Jiang F
AU  -  Ding N
AU  -  Ren B
AU  -  Li M.
PY  - 2026
JO  - Int J Radiat Oncol Biol Phys
DO  - 10.1016/j.ijrobp.2026.05.055
UR  - https://doi.org/10.1016/j.ijrobp.2026.05.055
ER  - 

APA

X, Z., L, Z., S, Z., H, G., N, J., H, Z., F, J., N, D., B, R., & M., L. (2026). Low-Dose Stereotactic Body Radiation Therapy-Based Radiation Therapy Followed by Pembrolizumab and Chemotherapy for Potentially Resectable Non-Small Cell Lung Cancer: A Phase 1b Study.. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2026.05.055

Source records